glp-1 and eye issues Ozempic Blindness: Should You Worry? Emerging Concerns: GLP-1 Modulators and

Eur J Cardiothorac Surg

it profoundly affects the autonomic nervous system (ANS) and cardiovascular function

Li J, Dong XQ, Cao LH, Zhang ZQ, Zhao WF, Shang QH, Zhang DZ, Ma AL, Xie Q, Gui HL, Zhang G, Liu YX, Shang J, Xie SB, Liu YQ, Zhang C, Wang GQ, Zhao H, China HepB Related Fibrosis Assessment Research Group

The mixed solution will provide a single 10 mL dose which must be diluted prior to intravenous administration [see Dosage and Administration (2.3)]

Here is the published report: Title: Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis